Key Takeaways
- Veragrow has secured USD 5.2 million (equivalent to €4.5 million) to expand commercial operations, increase production capacity, and accelerate R&D.
- The investment round includes participation from Odyssée Venture, Normandie Participations, CEN Innovation (Caisse d’Épargne Normandie Innovation), and Groupe All Sun.
- Funding will support national and international expansion, including six new formulations planned for 2026.
- The company's lombricompost-derived biostimulants have shown strong performance across 930+ field trials.
- The company aims to become a leading global biostimulant manufacturer by 2030.
Veragrow Secures USD 5.2 Million to Scale Its Agricultural Biostimulants and Support Sustainable Farming
Veragrow, a French agribiotech company specializing in lombricompost-derived biostimulants, has raised USD 5.2 million in its latest funding round to accelerate commercial expansion and strengthen its position within the growing biostimulants market. The round was backed by Odyssée Venture, Normandie Participations, CEN Innovation, and Groupe All Sun.
The capital will help Veragrow reinforce its sales network, extend distribution domestically and internationally, expand production capacity at its Val-de-Reuil facility, and accelerate R&D activities to address increasing market demand.
Veragrow’s Technology Demonstrates Strong Agronomic Performance
Founded in 2019, Veragrow uses a proprietary extraction and stabilization process that isolates active compounds produced by more than 25 million earthworms converting agricultural co-products into high-value lombricompost.
